Trinity Biotech ADR buy StockNews.com
Start price
03.07.23
/
50%
€0.87
Target price
03.07.24
-
Performance (%)
-50.29%
End price
04.07.24
-
Summary
This prediction is currently being closed. Massive losses of -50.29% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | -3.935% | -2.628% | 10.013% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten